Menu
Sprycel is a medication prescribed for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) that are Philadelphia chromosome-positive. It works by inhibiting the activity of BCR-ABL and other tyrosine kinases, which are responsible for the growth of cancer cells.
Take Sprycel as directed by your healthcare provider, typically once daily, with or without food. The tablet should be swallowed whole not crush, split, or chew it.
Before starting Sprycel, inform your doctor if you have any history of heart problems, lung disease, or liver issues. Regular monitoring of blood counts and organ function is essential throughout the treatment period.
Sprycel should not be used if you are allergic to dasatinib or any of its ingredients. It should be used with caution in patients with bleeding disorders or severe pulmonary conditions.
Common side effects of Sprycel include fatigue, fluid retention, nausea, and diarrhea. Serious side effects may include pulmonary arterial hypertension, low blood counts, or bleeding complications.
Avoid taking Sprycel with strong CYP3A4 inhibitors or inducers. Grapefruit products should also be avoided, as they may interfere with the medication. Acid-reducing agents can affect the absorption of Sprycel.
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed one not double the dose.
Symptoms of an overdose may include severe fatigue, low blood counts, or abnormal heart rhythms. Seek immediate medical attention if an overdose is suspected.
Store Sprycel at room temperature, away from moisture and light. Keep it in its original container and out of reach of children.
The information provided here is intended for general understanding and does not cover all possible directions, drug interactions, or precautions. This content should not be used for self-treatment or self-diagnosis. Always consult your healthcare provider for specific instructions tailored to your condition. We are not responsible for any errors or omissions in the information or for any consequences resulting from its use or self-treatment.
